Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1281: In which of the following conditions are bacteria NOT typically shed?

A. Carrier state
B. Latent infection (Correct Answer)
C. Incubation period
D. Subclinical infection

Explanation: **Explanation:** The core concept tested here is the distinction between **infectivity** and **latency**. **1. Why Latent Infection is correct:** In a **Latent Infection**, the pathogen remains in a dormant or "hidden" state within the host tissues. During this phase, the organism is not actively replicating or shedding into the environment; therefore, the individual is **not infectious** to others. A classic example is Latent Tuberculosis, where *M. tuberculosis* is contained within granulomas but not coughed out. **2. Analysis of Incorrect Options:** * **Carrier State:** By definition, a carrier is an infected person who harbors a specific infectious agent in the absence of discernible clinical disease and serves as a **potential source of infection**. They actively shed the bacteria (e.g., Typhoid Mary). * **Incubation Period:** This is the time interval between exposure and the onset of clinical symptoms. In many diseases (e.g., Pertussis, Cholera), shedding begins during the late incubation period before symptoms appear. * **Subclinical Infection:** Also known as "asymptomatic infection," the host has an immune response but no clinical symptoms. However, active replication occurs, and the agent is shed (e.g., Polio, Hepatitis A). **Clinical Pearls for NEET-PG:** * **Latent vs. Incubation:** In the incubation period, the disease is progressing toward clinical illness. In latency, the disease is "halted" or dormant. * **Generation Time:** The interval between receipt of infection and maximal infectivity (shedding). * **Iceberg Phenomenon:** Subclinical cases and carriers form the submerged portion of the iceberg and are the most dangerous from an epidemiological standpoint because they continue to shed bacteria unnoticed.

Question 1282: Which of the following activities is not evaluated to determine the extent of goal achievement in a dracunculiasis elimination program?

A. Provision of protected water sources
B. Health education
C. Chemical disinfection of water sources
D. Registration of new cases (Correct Answer)

Explanation: ### Explanation **Dracunculiasis (Guinea Worm Disease)** is targeted for **eradication**, not just elimination. The evaluation of a program’s success depends on the effectiveness of the interventions implemented to break the chain of transmission. **Why "Registration of new cases" is the correct answer:** In the context of Guinea Worm, "Registration of new cases" is a **surveillance activity**, not an evaluative measure of goal achievement. To achieve eradication, the goal is **zero cases**. While case detection is vital for containment, the *extent of goal achievement* is measured by the successful implementation of preventive strategies (the process) and the ultimate interruption of transmission (the outcome). In many epidemiological frameworks, "registration" is the baseline data collection, whereas the other options are the specific "interventions" being evaluated for their coverage and efficacy. **Analysis of Incorrect Options:** * **A. Provision of protected water sources:** This is a primary intervention. Evaluating how much of the population has access to safe water (e.g., piped water or borehole wells) is a direct measure of program success. * **B. Health education:** Teaching communities to filter water using fine mesh cloth and to prevent infected persons from entering water bodies is a core pillar. The "change in behavior" is a key evaluation metric. * **C. Chemical disinfection of water sources:** The use of **Temephos (Abate)** to kill intermediate hosts (Cyclops) is a standard intervention. The percentage of water bodies treated is a critical evaluation parameter. ### NEET-PG High-Yield Pearls * **Agent:** *Dracunculus medinensis* (Nematode). * **Intermediate Host:** Cyclops (Water flea). * **Transmission:** Ingesting water containing Cyclops infected with L3 larvae. * **India Status:** India was declared **Guinea Worm free** by the WHO in **February 2000** (Last case reported in July 1996 in Rajasthan). * **Strategy:** The "Case Containment Strategy" is used, where every single case is treated as a public health emergency. * **Chemical of Choice:** **Temephos (Abate)** at 1 mg/L concentration.

Question 1283: Who is considered the father of modern epidemiological surveillance?

A. William Farr (Correct Answer)
B. James Lind
C. Edwin Chadwick
D. Pettenkofer

Explanation: **Explanation:** **William Farr (Option A)** is recognized as the **Father of Modern Epidemiological Surveillance**. As the compiler of abstracts for the General Register Office in England (1839), he developed a system for the routine collection of data on causes of death. He was the first to use vital statistics (mortality and morbidity data) to evaluate the health of populations, establish the concept of "population at risk," and demonstrate the relationship between mortality rates and population density. **Analysis of Incorrect Options:** * **James Lind (Option B):** Known as the "Father of Clinical Trials" for his landmark controlled trial on HMS Salisbury, which proved that citrus fruits (Vitamin C) could cure scurvy. * **Edwin Chadwick (Option C):** A pioneer of the "Sanitary Idea." He focused on environmental improvements (clean water, sewage) and is a key figure in the history of Public Health, but not surveillance specifically. * **Max von Pettenkofer (Option D):** Known as the "Father of Hygiene." He believed in the "multifactorial" cause of disease (the Miasma theory) and emphasized the role of soil and water in cholera transmission. **NEET-PG High-Yield Pearls:** * **John Snow:** Known as the **Father of Modern Epidemiology** (famous for the Broad Street pump cholera outbreak investigation). * **Hippocrates:** The **First Epidemiologist** (associated disease with environmental factors like air, water, and places). * **Surveillance vs. Survey:** Surveillance is a **continuous**, ongoing collection of data for action, whereas a survey is an **intermittent**, cross-sectional snapshot. * **Farr’s Law:** States that epidemics tend to rise and fall in a bell-shaped curve.

Question 1284: What is true regarding measles outbreaks?

A. Occurs if the proportion of susceptible children is greater than 20%
B. Infects 50% of children in a virgin community
C. Vaccination is given at 6 months (Correct Answer)
D. Occurs every 6-7 years

Explanation: **Explanation:** The correct answer is **C: Vaccination is given at 6 months.** While the routine Measles-Rubella (MR) vaccine is scheduled at 9 months, the WHO and National Guidelines state that during a **measles outbreak**, a "supplementary dose" or "outbreak response immunization" can be administered as early as **6 months of age**. This dose is considered "extra" and does not count towards the routine schedule. **Analysis of Options:** * **A: Proportion of susceptible children:** An outbreak typically occurs when the proportion of susceptible children in a population exceeds **10%**, not 20%. Maintaining herd immunity requires >90-95% coverage. * **B: Virgin Community:** In a "virgin community" (where the virus has never been introduced), measles is highly infectious, typically affecting **nearly 100%** of the susceptible population, not 50%. * **D: Periodicity:** In the pre-vaccination era, measles epidemics occurred in cycles every **2–3 years**, not 6–7 years. Vaccination has significantly altered this periodicity. **High-Yield Clinical Pearls for NEET-PG:** * **Infectivity:** Measles is most infectious during the **prodromal/catarrhal stage** (before the rash appears). * **Secondary Attack Rate (SAR):** It has a very high SAR of **>80%** among susceptible household contacts. * **Vitamin A:** Regardless of the previous dose, two doses of Vitamin A (24 hours apart) are mandatory for all children diagnosed with measles to prevent complications like blindness and pneumonia. * **Isolation:** Cases should be isolated for **4 days after the appearance of the rash**.

Question 1285: Immunization is a form of:

A. Primary prevention (Correct Answer)
B. Secondary prevention
C. Tertiary prevention
D. Disability limitation

Explanation: **Explanation:** **1. Why Primary Prevention is Correct:** Primary prevention aims to prevent the onset of disease by altering susceptibility or reducing exposure for susceptible individuals. It is applied during the **pre-pathogenesis phase** (before the disease process has started). Immunization is the classic example of **Specific Protection**, which is a mode of intervention under primary prevention. By administering vaccines, we bolster the host's immune system to prevent the disease from ever occurring. **2. Why Other Options are Incorrect:** * **Secondary Prevention:** This focuses on **early diagnosis and prompt treatment**. It aims to halt the disease progress and prevent complications (e.g., Pap smears for cervical cancer or sputum microscopy for TB). Since immunization happens before the disease starts, it cannot be secondary. * **Tertiary Prevention:** This occurs during the late pathogenesis phase. It aims to reduce impairments and disabilities (e.g., cardiac rehabilitation). * **Disability Limitation:** This is a mode of intervention under **Tertiary Prevention**. It involves preventing the transition from disease to permanent impairment or disability. **Clinical Pearls for NEET-PG:** * **Primordial Prevention:** Prevention of the *emergence* of risk factors (e.g., discouraging children from starting smoking). * **Primary Prevention Modes:** Includes Health Promotion (general) and Specific Protection (immunization, chemoprophylaxis, use of helmets). * **Quaternary Prevention:** Actions taken to identify patients at risk of over-medicalization and protecting them from new medical invasions. * **Catchphrase:** Primary = "Prevention of occurrence"; Secondary = "Prevention of progression."

Question 1286: What is the time interval between the inoculation of an infection and the point of maximum infectivity?

A. Lead time
B. Median incubation period
C. Generation time (Correct Answer)
D. Serial interval

Explanation: ### Explanation **Correct Answer: C. Generation time** **Understanding the Concept:** In epidemiology, **Generation Time** is defined as the interval between the receipt of infection (inoculation) and the point of **maximum infectivity** of the host. It represents the time required for a host to become most capable of transmitting the pathogen to others. This concept is crucial for understanding the speed of an epidemic's spread; shorter generation times lead to more rapid outbreaks. **Analysis of Incorrect Options:** * **A. Lead time:** This is the period between the early detection of a disease (usually through screening) and the time when it would have been diagnosed due to the onset of clinical symptoms. It is a measure of the "head start" gained by screening. * **B. Median incubation period:** The incubation period is the time from inoculation to the **onset of clinical signs/symptoms**. The "median" refers to the time by which 50% of infected individuals show symptoms. It focuses on clinical disease, not infectivity. * **C. Serial interval:** This is the time gap between the onset of the primary case and the onset of the secondary case in a transmission chain. While generation time is a biological parameter of the individual, the serial interval is the observable clinical counterpart used in field investigations. **High-Yield Clinical Pearls for NEET-PG:** * **Generation Time vs. Incubation Period:** If the generation time is shorter than the incubation period (e.g., in HIV or Hepatitis B), the person is most infectious *before* symptoms appear, making the disease harder to control. * **Serial Interval:** In most practical scenarios, the Serial Interval is used as a proxy for Generation Time because the exact moment of inoculation is often unknown. * **Latent Period:** The interval between inoculation and the point when the person *starts* becoming infectious (not maximum infectivity).

Question 1287: Which of the following is the MOST cost-effective method of screening for a particular disease in a community?

A. Multiphasic screening
B. Mass screening
C. High-risk screening (Correct Answer)
D. Any of the above

Explanation: ### Explanation **Correct Answer: C. High-risk screening** **Why High-risk screening is the correct answer:** High-risk screening (also known as selective screening) targets individuals who are at a higher risk of developing a specific disease based on the presence of certain risk factors (e.g., screening heavy smokers for lung cancer or obese individuals for Type 2 Diabetes). From an epidemiological standpoint, this method is the most **cost-effective** because: 1. **Higher Yield:** It increases the "Pretest Probability," leading to a higher **Positive Predictive Value (PPV)**. 2. **Resource Optimization:** It minimizes the number of tests performed on healthy individuals who are unlikely to have the disease, thereby reducing expenditure and unnecessary medical interventions. **Why other options are incorrect:** * **A. Multiphasic screening:** This involves the application of two or more screening tests to a large population at once. While efficient for data collection, it is expensive and often leads to "over-diagnosis" or false positives, making it less cost-effective. * **B. Mass screening:** This refers to screening the entire population (e.g., chest X-rays for TB in the general public). It is resource-intensive, expensive, and has a low yield if the disease prevalence is low, leading to a high cost-per-case detected. * **D. Any of the above:** Incorrect, as high-risk screening is specifically superior in terms of cost-benefit ratio. **NEET-PG High-Yield Pearls:** * **Screening vs. Diagnostic Test:** Screening is done on apparently healthy individuals; diagnostic tests are for those with symptoms. * **Predictive Value:** The Positive Predictive Value of a screening test is directly proportional to the **prevalence** of the disease in the population being screened. This is why high-risk screening (high prevalence group) is more effective. * **Iceberg Phenomenon:** Screening is primarily aimed at detecting the "submerged portion" of the iceberg (pre-symptomatic/latent cases).

Question 1288: Confounding cannot be removed by which of the following methods?

A. Assigning confounders to both cases and controls
B. Stratification
C. Matching
D. Randomization (Correct Answer)

Explanation: ### Explanation The question asks which method **cannot** remove confounding. In epidemiological studies, confounding occurs when an external variable is associated with both the exposure and the outcome, potentially distorting the true relationship. **Why Randomization is the Correct Answer (in this context):** There is a subtle but critical distinction in epidemiology: Randomization is used to **prevent** or **control** confounding at the **design stage** of a study (especially in RCTs). However, once a study is completed and data is being analyzed, if confounding is already present, randomization cannot "remove" it. *Note for NEET-PG:* While randomization is the "gold standard" for controlling both known and unknown confounders, the phrasing "cannot be removed" often refers to the **analysis phase** or the fact that randomization can occasionally fail in small samples, leaving residual confounding. **Analysis of Other Options:** * **Matching (C):** A design-stage method where controls are selected to have the same confounding variables (e.g., age, sex) as cases, effectively neutralizing their effect. * **Stratification (B):** An analysis-stage method where data is divided into sub-groups (strata) based on the confounder (e.g., analyzing smokers and non-smokers separately) to see the true effect of the exposure. * **Assigning confounders to both groups (A):** This is the conceptual basis of matching or restriction; by ensuring the confounder is present equally in both groups, its influence is cancelled out. **High-Yield Clinical Pearls for NEET-PG:** 1. **Methods to control confounding at the DESIGN stage:** Randomization (best for unknown confounders), Matching, and Restriction. 2. **Methods to control confounding at the ANALYSIS stage:** Stratification and Multivariate Analysis (e.g., Logistic Regression). 3. **Randomization** is the only method that controls for **unknown** confounding variables. 4. **Confounder Criteria:** It must be a risk factor for the disease, associated with the exposure, and NOT an intermediate step in the causal pathway.

Question 1289: What does a relative risk of 5 signify?

A. 50% of the disease among the exposed is due to exposure to the risk factor.
B. 50% of the disease is attributable to risk factors.
C. The incidence of disease is 5 times higher in the exposed group compared to the unexposed group. (Correct Answer)
D. The incidence of disease is 50% higher in the exposed group compared to the unexposed group.

Explanation: **Explanation:** **Relative Risk (RR)**, also known as Risk Ratio, is a measure of the strength of association between an exposure and an outcome. It is calculated as the ratio of the **Incidence of disease among the exposed** to the **Incidence of disease among the unexposed**. 1. **Why Option C is Correct:** A Relative Risk of 5 means that the numerator (Incidence in exposed) is 5 times larger than the denominator (Incidence in unexposed). Therefore, the disease is 5 times more likely to occur in individuals exposed to the risk factor compared to those not exposed. 2. **Why Other Options are Incorrect:** * **Options A & B:** These refer to **Attributable Risk (AR)** or **Proportional Attributable Risk**. AR measures the amount of disease incidence that can be directly blamed on the exposure. A RR of 5 does not mathematically translate to 50% attribution; in fact, the formula for Attributable Risk Proportion is $[(RR-1)/RR] \times 100$. For a RR of 5, the AR% would be 80%. * **Option D:** A 50% higher incidence would correspond to a Relative Risk of **1.5**. A RR of 5 represents a 400% increase (or 5-fold total risk). **NEET-PG High-Yield Pearls:** * **RR = 1:** No association between exposure and disease. * **RR > 1:** Positive association (Risk factor). * **RR < 1:** Negative association (Protective factor, e.g., vaccines). * **Study Design:** Relative Risk is directly calculated from **Cohort Studies**. In Case-Control studies, we use **Odds Ratio (OR)** as an estimate of RR. * **Clinical Significance:** While RR measures the *strength* of association (etiology), Attributable Risk measures the *public health impact*.

Question 1290: Due to an effective prevention program, the prevalence of an infectious disease in a community has been reduced by 90%. A physician continues to use the same diagnostic test for the disease that she has always used. How have the test’s characteristics changed?

A. Its sensitivity has increased
B. Its positive predictive value has increased
C. The test’s characteristics have not changed
D. Its negative predictive value has increased (Correct Answer)

Explanation: ### Explanation The core concept tested here is the relationship between **disease prevalence** and **predictive values**. **1. Why Option D is Correct:** Negative Predictive Value (NPV) is the probability that a person who tests negative truly does not have the disease. NPV is **inversely proportional** to prevalence. When the prevalence of a disease decreases (in this case, by 90%), the number of "True Negatives" in the population increases significantly relative to "False Negatives." Therefore, a negative test result becomes even more reliable, leading to an **increase in NPV**. **2. Why the Other Options are Incorrect:** * **Option A & C:** Sensitivity and Specificity are **intrinsic properties** of a diagnostic test. They depend on the test’s design (e.g., the cutoff point) and are independent of the prevalence of the disease in the population. Thus, they remain unchanged. * **Option B:** Positive Predictive Value (PPV) is **directly proportional** to prevalence. As prevalence falls, the likelihood that a positive result is a "False Positive" increases. Therefore, the PPV would **decrease**, not increase. **3. High-Yield Clinical Pearls for NEET-PG:** * **Prevalence $\uparrow$:** PPV increases, NPV decreases. * **Prevalence $\downarrow$:** PPV decreases, NPV increases. * **Sensitivity/Specificity:** These are fixed characteristics of the test and do not change with prevalence. * **Screening in Low-Prevalence Areas:** When screening for rare diseases, the PPV is usually low, meaning many positive results will be false positives. This is why confirmatory tests are essential. * **Formula Recall:** * $PPV = \text{True Positives} / (\text{True Positives} + \text{False Positives})$ * $NPV = \text{True Negatives} / (\text{True Negatives} + \text{False Negatives})$

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free